PROK2 and Parkinson disease: In fact, in ONs from PD patients, SP levels rise proportionally with the clinical severity, operating as a pathogenic force [22–24], while PK2 expression follows oligomeric α-synuclein accumulation, providing a sort of defensive response [11, 25, 26].